{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:15:11Z","timestamp":1783394111081,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.fct.2026.116225","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:22:49Z","timestamp":1781994169000},"page":"116225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disproportionality analysis of dietary supplement adverse events in the FDA CAERS database, 2004\u20132025"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6226-440X","authenticated-orcid":false,"given":"Hayden","family":"Farquhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2026.116225_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2026.116225_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib3","doi-asserted-by":"crossref","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"2008","author":"Blondel","year":"2008","journal-title":"J. Stat. Mech."},{"key":"10.1016\/j.fct.2026.116225_bib4","series-title":"Practical Aspects of Signal Detection in Pharmacovigilance: Report of CIOMS Working Group VIII","year":"2010"},{"key":"10.1016\/j.fct.2026.116225_bib5","series-title":"2024 CRN Consumer Survey on Dietary Supplements","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib6","first-page":"109","article-title":"DSCPA (dietary supplement and nonprescription drug consumer protection act)","year":"2006","journal-title":"Pub. L."},{"key":"10.1016\/j.fct.2026.116225_bib7","first-page":"103","article-title":"DSHEA (Dietary supplement health and education act)","year":"1994","journal-title":"Pub. L."},{"key":"10.1016\/j.fct.2026.116225_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am. Stat."},{"key":"10.1016\/j.fct.2026.116225_bib9","article-title":"Scientific opinion on the safety of green tea catechins","volume":"16","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.fct.2026.116225_bib10","article-title":"Scientific opinion on the tolerable upper intake level for vitamin B6","volume":"21","year":"2023","journal-title":"EFSA J."},{"key":"10.1016\/j.fct.2026.116225_bib11","series-title":"Screening for Adverse Reactions in Eudravigilance","year":"2016"},{"key":"10.1016\/j.fct.2026.116225_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib13","first-page":"6788","article-title":"Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk","volume":"69","year":"2004","journal-title":"Fed. Regist."},{"key":"10.1016\/j.fct.2026.116225_bib14","series-title":"Hydroxycut Products Recall","year":"2009"},{"key":"10.1016\/j.fct.2026.116225_bib15","series-title":"Import Alert 54-15: Detention Without Physical Examination of Dietary Supplements and Bulk Dietary Ingredients that are or Contain Mitragyna speciosa or Kratom","year":"2014"},{"key":"10.1016\/j.fct.2026.116225_bib19","series-title":"CFSAN Adverse Event Reporting System (CAERS): FDA Open Data","year":"2025"},{"key":"10.1016\/j.fct.2026.116225_bib16","series-title":"FDA Announces Reorganization of Human Foods Program","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib17","series-title":"CFSAN Adverse Event Reporting System (CAERS)","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib18","series-title":"FDA and Kratom","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/ajg.2010.5","article-title":"Hepatotoxicity due to hydroxycut: a case series","volume":"105","author":"Fong","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.fct.2026.116225_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","article-title":"The role of data mining in pharmacovigilance","volume":"4","author":"Hauben","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-200932020-00003","article-title":"Defining \u2018signal\u2019 and its subtypes in pharmacovigilance based on a systematic review of previous definitions","volume":"32","author":"Hauben","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib24","series-title":"Medical Dictionary for Regulatory Activities (Meddra)","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.fct.2026.116225_bib26","first-page":"1","volume":"vol. 399","author":"Mishra","year":"2021"},{"key":"10.1016\/j.fct.2026.116225_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2026.116225_bib28","series-title":"Dietary Supplement Label Database (DSLD)","year":"2024"},{"key":"10.1016\/j.fct.2026.116225_bib29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15585\/mmwr.mm6814a2","article-title":"Notes from the field: unintentional drug overdose deaths with kratom detected \u2014 27 states, July 2016\u2013December 2017","volume":"68","author":"Olsen","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.fct.2026.116225_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/biomet\/41.1-2.100","article-title":"Continuous inspection schemes","volume":"41","author":"Page","year":"1954","journal-title":"Biometrika"},{"key":"10.1016\/j.fct.2026.116225_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib33","series-title":"Vitamin B6 (Pyridoxine)","year":"2022"},{"key":"10.1016\/j.fct.2026.116225_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1060028017744316","article-title":"Dietary supplement adverse event report data from the FDA center for food safety and applied nutrition adverse event reporting system (CAERS), 2004\u20132013","volume":"52","author":"Timbo","year":"2018","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.fct.2026.116225_bib35","first-page":"258","article-title":"Detecting signals of dietary supplement adverse events from the CFSAN adverse event reporting system (CAERS)","volume":"2019","author":"Vasilakes","year":"2019","journal-title":"AMIA Jt. Summits Transl. Sci. Proc."},{"key":"10.1016\/j.fct.2026.116225_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40264-016-0405-1","article-title":"Good signal detection practices: evidence from IMI PROTECT","volume":"39","author":"Wisniewski","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2026.116225_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.fct.2026.116225_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1438292","article-title":"Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2026.116225_bib39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/14740338.2024.2410436","article-title":"A real-world pharmacovigilance study using disproportionality analysis of United States food and drug administration adverse event reporting system events for vinca alkaloids: comparing vinorelbine and vincristine","volume":"23","author":"Zhong","year":"2024","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:39:52Z","timestamp":1783391992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691526002991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S0278691526002991"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2026.116225","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.177383914.49860394\/v1","asserted-by":"object"}]},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disproportionality analysis of dietary supplement adverse events in the FDA CAERS database, 2004\u20132025","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2026.116225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116225"}}